tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMMP Stock Latest News

Immutep Advances Novel Autoimmune Therapy with Phase I Trial
Company AnnouncementsImmutep Advances Novel Autoimmune Therapy with Phase I Trial
5d ago
6K
IMMP
Immutep engers agreement with Centre for Human Drug Research
PremiumThe Fly
Immutep engers agreement with Centre for Human Drug Research
6d ago
IMMP
Immutep receives feedback from the Spanish AEMPS for TACTI-004 trial
PremiumThe Fly
Immutep receives feedback from the Spanish AEMPS for TACTI-004 trial
7d ago
IMMP
Immutep announces first clinical data from 90mg dosing of efti
PremiumThe Fly
Immutep announces first clinical data from 90mg dosing of efti
2M ago
IMMP
Immutep reports Q2 cash receipts $38K vs. $132K last quarter
PremiumThe Fly
Immutep reports Q2 cash receipts $38K vs. $132K last quarter
3M ago
IMMP
Immutep announces first patient enrolled, dosed in INSIGHT-005 trial
PremiumThe FlyImmutep announces first patient enrolled, dosed in INSIGHT-005 trial
4M ago
IMMP
Immutep receives constructive feedback on TACTI-004 trial
PremiumThe Fly
Immutep receives constructive feedback on TACTI-004 trial
4M ago
IMMP
Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
PremiumPress Releases
Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
4M ago
IMMP
Immutep receives EUR 1.595M R&D tax incentive from French government
PremiumThe Fly
Immutep receives EUR 1.595M R&D tax incentive from French government
5M ago
IMMP
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
PremiumPress Releases
Immutep Receives A$2.6 million R&D Tax Incentive from French Government
5M ago
IMMP
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
PremiumPress Releases
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
5M ago
IMMP
Immutep announces site expansion for INSIGHT-003 Phase I trial
PremiumThe Fly
Immutep announces site expansion for INSIGHT-003 Phase I trial
5M ago
IMMP
Immutep completes enrollment in TACTI-003 Phase IIb trial
PremiumThe FlyImmutep completes enrollment in TACTI-003 Phase IIb trial
6M ago
IMMP
Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
PremiumPress Releases
Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
6M ago
IMMP
Immutep announces completion of lead-in, opening of Phase II study of AIPAC-003
PremiumThe Fly
Immutep announces completion of lead-in, opening of Phase II study of AIPAC-003
6M ago
IMMP
Immutep announces new biomarker data from TACTI-002 Phase II
PremiumThe Fly
Immutep announces new biomarker data from TACTI-002 Phase II
6M ago
IMMP
Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung Cancer
PremiumPress Releases
Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung Cancer
6M ago
IMMP
Immutep reports Q1 cash receipts $132K vs. $16K last quarter
PremiumThe Fly
Immutep reports Q1 cash receipts $132K vs. $16K last quarter
6M ago
IMMP
Immutep receives A$1,134,882 R&D tax incentive
PremiumThe Fly
Immutep receives A$1,134,882 R&D tax incentive
6M ago
IMMP
Immutep reports clinical data from INSIGHT-003 trial
PremiumThe FlyImmutep reports clinical data from INSIGHT-003 trial
6M ago
IMMP
Immutep announces new data from TACTI-002 / KEYNOTE-798 Phase II trial
PremiumThe Fly
Immutep announces new data from TACTI-002 / KEYNOTE-798 Phase II trial
6M ago
IMMP
Immutep announces regulatory authorization for eftilagimod alpha manufacturing
PremiumThe Fly
Immutep announces regulatory authorization for eftilagimod alpha manufacturing
7M ago
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >